Published in J Pediatr Surg on November 01, 1999
Bladder wrap: a technique to restore continence in an incompetent vesicocutaneous diversion. Ann R Coll Surg Engl (2012) 0.75
Assessment of physician performance in Alberta: the physician achievement review. CMAJ (1999) 4.67
Intrapleural therapy for malignant pleural effusions. A randomized comparison of bleomycin and tetracycline. Chest (1991) 1.72
Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity. Indian J Med Res (2008) 1.47
Improved cartilage fixation by ruthenium hexammine trichloride (RHT). A prerequisite for morphometry in growth cartilage. J Ultrastruct Res (1982) 1.34
RU 486: a steroid with antiglucocorticosteroid activity that only disinhibits the human pituitary-adrenal system at a specific time of day. Proc Natl Acad Sci U S A (1984) 1.30
[The effects of an antiprogesterone steroid in women: interruption of the menstrual cycle and of early pregnancy]. C R Seances Acad Sci III (1982) 1.26
Ruthenium hexammine trichloride (RHT)-mediated interaction between plasmalemmal components and pericellular matrix proteoglycans is responsible for the preservation of chondrocytic plasma membranes in situ during cartilage fixation. J Histochem Cytochem (1983) 1.23
Amniotic fluid and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A) throughout pregnancy: comparison with other fetoplacental products. Br J Obstet Gynaecol (1982) 1.20
Matrix compartments in the growth plate of the proximal tibia of rats. Anat Rec (1985) 1.07
Cartilage ultrastructure after high pressure freezing, freeze substitution, and low temperature embedding. I. Chondrocyte ultrastructure--implications for the theories of mineralization and vascular invasion. J Cell Biol (1984) 1.06
Karyotype, phenotype and parental origin in 19 cases of triploidy. Prenat Diagn (2001) 1.04
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.02
Radioimmunoassay for the measurement of pregnancy-associated plasma protein-A (PAPP-A) in humans. Biol Reprod (1981) 1.02
Small bowel perforation in the premature neonate: congenital or acquired? Pediatr Surg Int (2003) 1.01
A novel germ line mutation in SOX9 causes familial campomelic dysplasia and sex reversal. Hum Mol Genet (1996) 1.00
Testicular and paratesticular tumours in children: 30 years' experience. Aust N Z J Surg (1999) 0.96
Preservation of cartilage matrix proteoglycans using cationic dyes chemically related to ruthenium hexaammine trichloride. J Histochem Cytochem (1992) 0.95
Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Z Kardiol (2004) 0.90
Genetic defects as important factors for moderate hyperhomocysteinemia. Clin Chem Lab Med (2001) 0.89
Prevalences of hyperhomocysteinemia, unfavorable cholesterol profile and hypertension in European populations. Eur J Clin Nutr (2005) 0.89
Noncervicofacial atypical mycobacterial lymphadenitis in childhood. J Pediatr Surg (2001) 0.88
Hyperhomocysteinemia is associated with impaired fracture healing in mice. Calcif Tissue Int (2009) 0.87
Exercise-induced increases in NT-proBNP are not related to the exercise-induced immune response. Br J Sports Med (2008) 0.86
Tissue and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A): comparison with other fetoplacental products. Br J Obstet Gynaecol (1982) 0.86
Physician supply in rural Canada. Can urban medical schools produce rural physicians? Can Fam Physician (1996) 0.84
Does statin therapy influence steroid hormone synthesis? Z Kardiol (2004) 0.84
Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy. Br J Obstet Gynaecol (1981) 0.84
Artifact processing in computerized analysis of sleep EEG - a review. Neuropsychobiology (1999) 0.84
Preclinical evaluation of a prostate-targeted gene-directed enzyme prodrug therapy delivered by ovine atadenovirus. Gene Ther (2004) 0.83
[Effects of ovarian stimulation on serum concentrations of lipids and ketone bodies in patients undergoing IVF/ICSI treatment]. Zentralbl Gynakol (2004) 0.82
Interpretation of alpha-fetoprotein concentrations in cerebrospinal fluid of infants. Ann Clin Biochem (2005) 0.82
Is longitudinal bone growth influenced by diurnal variation in the mitotic activity of chondrocytes of the growth plate? J Orthop Res (1990) 0.80
Comparison of the effects on lipoproteins and apolipoproteins of a diet high in monounsaturated fatty acids, enriched with avocado, and a high-carbohydrate diet. Am J Clin Nutr (1992) 0.80
[Primary shape change of platelets in vitro (author's transl)]. Blut (1978) 0.80
Endometrial and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A). Br J Obstet Gynaecol (1982) 0.80
Stimulation of precipitation of calcium phosphate by matrix vesicles. Biochem J (1978) 0.80
Deficiencies of folate and vitamin B12 do not affect fracture healing in mice. Bone (2010) 0.79
Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease. Angiology (2000) 0.79
The clinical use of RU 486 (Mefipristone). Res Reprod (1989) 0.78
Measurement of thiols in human plasma using liquid chromatography with precolumn derivatization and fluorescence detection. J Chromatogr Sci (1999) 0.78
Effects of bunazosin and atenolol on serum lipids and apolipoproteins in a randomised trial. Blood Press (1996) 0.78
Ocular delivery systems for poorly soluble drugs: an in-vivo evaluation. Int J Pharm (2013) 0.78
[Laser epithelial keratomileusis (LASEK) for treatment of myopia up to -6.0 D. Results from 108 eyes after 12 months]. Ophthalmologe (2004) 0.78
[Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis]. Ann Endocrinol (Paris) (1983) 0.78
Fluorescence-based single-strand conformation polymorphism analysis of the low density lipoprotein receptor gene by capillary electrophoresis. J Chromatogr B Biomed Sci Appl (1999) 0.78
In situ localization of cartilage extracellular matrix components by immunoelectron microscopy after cryotechnical tissue processing. J Histochem Cytochem (1987) 0.77
Differential staining of calcified tissues in plastic embedded microtome sections by a modification of Movat's pentachrome stain. Stain Technol (1977) 0.77
Bisphosphonates and nephrocalcinosis in a rabbit leg lengthening model: a histological and therapeutic comparison. Pharmacol Toxicol (2001) 0.77
Fluorescence-based single-strand conformation polymorphism analysis of mutations by capillary electrophoresis. Electrophoresis (2000) 0.76
Reference standardization and triglyceride interference of a new homogeneous HDL-cholesterol assay compared with a former chemical precipitation assay. Clin Chem (1998) 0.76
[Modification of the atherogenic risk factor Lp(a) by supplementary fish oil administration in patients with moderate physical training]. Med Klin (Munich) (1989) 0.76
Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J Control Release (2007) 0.76
Nurse practitioners and family medicine. CMAJ (1992) 0.75
Carrot juice junkies and big bangs. Fertil Steril (1998) 0.75
[The behavior of specific parameters of lipid and lipoprotein metabolism in metabolically healthy and obese subjects]. Z Gesamte Inn Med (1982) 0.75
[Specificity and sensitivity of lipoprotein lipids in normal persons and cardiovascular patients]. Z Gesamte Inn Med (1985) 0.75
Spatial impulse response of lithographic infrared antennas. Appl Opt (1999) 0.75
Image analysis of electron micrographs relating to mineralization in calcifying cartilage: theoretical considerations. J Electron Microsc Tech (1989) 0.75
[Long-term oil therapy in elderly patients with peripheral arterial occlusive disease]. Z Alternsforsch (1985) 0.75
[Test on the elasticity of prosthetic materials. Proposal for the extension of the FDI-Specifications]. Zahnarztl Mitt (1967) 0.75
[An eicosapentaenoic acid-rich diet in relation to a reducing diet and physical training]. Z Gesamte Inn Med (1987) 0.75
[Speech therapy for children with cleft lips and palates. I. Basic linguistic considerations]. Dtsch Z Mund Kiefer Gesichtschir (1990) 0.75
[Treatment of disorders of lipid metabolism with the new lipid regulator X50]. Z Gesamte Inn Med (1986) 0.75
Tunable polarization response of a planar asymmetric-spiral infrared antenna. Opt Lett (1998) 0.75
[Behavior of the biological aging index and serum lipids in treatment with X50]. Z Alternsforsch (1986) 0.75
[Is cholesterol lowering following UVA blood irradiation an effect of citrate?]. Z Gesamte Inn Med (1984) 0.75
Stability of serum beta-crosslaps during storage: influence of pH and storage temperature. Clin Chem (2001) 0.75
[Sports therapy in obesity and lipid metabolism disorders]. Z Gesamte Inn Med (1987) 0.75
Eight novel LDL receptor gene mutations among patients under LDL apheresis in Dresden and Leipzig. Hum Mutat (2001) 0.75
[Postprandial hyperlipemia, circadian rhythm and the stress test in lipid metabolism]. Z Gesamte Inn Med (1986) 0.75
The role of gastric and duodenal pH in the cysteamine-induced duodenal ulcer in the rat. Acta Physiol Hung (1989) 0.75
[Modification of selected lipoproteins and blood pressure by different dosages of n-3-fatty acids]. Z Gesamte Inn Med (1990) 0.75
[The high risk patient (case report)]. Z Arztl Fortbild (Jena) (1991) 0.75
Homocysteine levels in patients treated with lipid apheresis: effect of a vitamin therapy. Eur J Clin Invest (2001) 0.75
The determination of chromosomal sex by oral smears. 1956. Yale J Biol Med (2001) 0.75
[Decreasing atherogenic risks by an eicosapentaenoic acid-rich diet]. Z Gesamte Inn Med (1987) 0.75
Bioavailability of slow-release co-dergocrine mesylate (dihydroergotoxine) formulations. Int J Clin Pharmacol Ther Toxicol (1987) 0.75
[In vivo effects of high density lipoprotein rich serum fractions (HDLF) in the human. 2. Effect of repeated HDLF infusions on atherogenic risk factors and arteriosclerotic vascular changes in patients with and without hyperlipoproteinemia]. Z Gesamte Inn Med (1989) 0.75
[Lipid metabolism and peripheral hemodynamics in arteriosclerosis obliterans treated with nifedipine--a comparison with pentoxifylline]. Z Gesamte Inn Med (1989) 0.75
[Long-term oil therapy and lipid metabolism in peripheral arterial obstructive disease]. Z Gesamte Inn Med (1985) 0.75
[The lipoprotein profile of hypertensive patients and its modification by 4 weeks of physical training during spa treatment]. Z Gesamte Inn Med (1985) 0.75
Where are we standing in homocysteine research? Clin Chem Lab Med (2003) 0.75
Lipids and lipoproteins as risk indicators for coronary heart disease (a study on male patients with defined vessel findings). Przegl Lek (1989) 0.75
[In vivo effects of high density lipoprotein rich serum fractions (HDLF) in the human. 1. Modification of circulating thrombocyte aggregates, cardiovascular parameters and lipid metabolism by HDLF]. Z Gesamte Inn Med (1989) 0.75
[Triglyceride profile following oil administration]. Z Gesamte Inn Med (1986) 0.75
[Lipids and apolipoproteins in relation to the degree of coronary sclerosis]. Z Gesamte Inn Med (1986) 0.75
Polarization response of asymmetric-spiral infrared antennas. Appl Opt (1997) 0.75
[Familial disorders of lipid metabolism in childhood]. Z Arztl Fortbild (Jena) (1986) 0.75
[Therapy of mild to moderate hypertension. Efficacy and tolerance of Amlodipine in comparison with the combination nifedipine/mefruside]. Fortschr Med (1991) 0.75
Fluorescence-based SSCP analysis with automatic allele detection demonstrated for the factor V Leiden mutation. Clin Chem (1998) 0.75
[Association between ovarian stimulation regime and protein metabolism of patients undergoing IVF/ICSI therapy]. Zentralbl Gynakol (2003) 0.75
[Dietary treatment of hyper- and dyslipoproteinemias]. Z Arztl Fortbild (Jena) (1990) 0.75
Mutation analysis of exon 3 of the LDL receptor gene in patients with severe hypercholesterolemia. Clin Chem Lab Med (1998) 0.75
[Venous thromboembolism in a young patient. Diagnosis: Retinal vein thromboembolism in mutation of the methylenetetrahydrofolate reductase gene]. Ophthalmologe (1999) 0.75
Co-dergocrine plasma concentrations and blood pressure changes in hypertensive patients during therapy with slow-release co-dergocrine mesylate. Int J Clin Pharmacol Ther Toxicol (1992) 0.75
Placental and circulating pregnancy-associated plasma protein A concentrates in normal and pathological term pregnancies. Obstet Gynecol (1986) 0.75
Historical aspects and perspectives in homocysteine research. Clin Chem Lab Med (2001) 0.75
[Real-time sonography in deep thrombosis of the pelvic and leg veins. A prospective comparison to phlebography]. Med Klin (Munich) (1991) 0.75
[CT and MRI in pronounced dysplastic cranial changes in the framework of McCune-Albright syndrome]. Rofo (1998) 0.75